help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sappino, A. P.
Right arrow Articles by Gabbiani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sappino, A. P.
Right arrow Articles by Gabbiani, G.

American Journal of Pathology, Vol 137, 585-591, Copyright © 1990 by American Society for Investigative Pathology


REGULAR ARTICLES

Smooth muscle differentiation in scleroderma fibroblastic cells

AP Sappino, I Masouye, JH Saurat and G Gabbiani
Division of Onco-Hematology, University Hospital of Geneva, Switzerland.

Using antibodies to alpha-smooth muscle actin and desmin on paraffin- embedded formalin-fixed tissue sections, the authors demonstrate that fibroblastic cells of localized and systemic scleroderma lesions express features of smooth muscle differentiation. Eleven of eleven skin specimens of systemic sclerosis patients and two of four skin specimens of localized scleroderma displayed the presence of fibroblasts expressing alpha-smooth muscle actin, a cell population that predominated in areas of prominent collagen deposition. A similar fibroblastic phenotype was found in the esophagus, the liver, and the lung specimens obtained from four patients who died of progressive systemic sclerosis. Immunostaining for desmin, performed on adjacent tissue sections, demonstrated that a minority of these fibroblastic cells present in skin and visceral lesions contained this protein. The authors' observations indicate that scleroderma fibroblasts are phenotypically related to the stromal cells previously identified in hypertrophic scars, fibromatoses, and desmoplasia; they might provide novel criteria for the characterization of scleroderma lesions and help to identify the factors responsible for phenotypic modulations in fibroblastic cells.


This article has been cited by other articles:


Home page
J EndocrinolHome page
G. J Allan, J. Beattie, and D. J Flint
Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5
J. Endocrinol., November 1, 2008; 199(2): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. S. Greenberg, A. M. Bernstein, M. Benezra, I. H. Gelman, L. Taliana, and S. K. Masur
FAK-dependent regulation of myofibroblast differentiation
FASEB J, May 1, 2006; 20(7): 1006 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Shi-Wen, Y. Chen, C. P. Denton, M. Eastwood, E. A. Renzoni, G. Bou-Gharios, J. D. Pearson, M. Dashwood, R. M. du Bois, C. M. Black, et al.
Endothelin-1 Promotes Myofibroblast Induction through the ETA Receptor via a rac/Phosphoinositide 3-Kinase/Akt-dependent Pathway and Is Essential for the Enhanced Contractile Phenotype of Fibrotic Fibroblasts
Mol. Biol. Cell, June 1, 2004; 15(6): 2707 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Koumas, T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps
Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes
Am. J. Pathol., October 1, 2003; 163(4): 1291 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Tokunou, T. Niki, K. Eguchi, S. Iba, H. Tsuda, T. Yamada, Y. Matsuno, H. Kondo, Y. Saitoh, H. Imamura, et al.
c-MET Expression in Myofibroblasts : Role in Autocrine Activation and Prognostic Significance in Lung Adenocarcinoma
Am. J. Pathol., April 1, 2001; 158(4): 1451 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
L. I Romero, D.-N. Zhang, J. P Cooke, H.-K. V Ho, E. Avalos, R. Herrera, and G S. Herron
Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma
Vascular Medicine, August 1, 2000; 5(3): 147 - 158.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, and A. B. West
Myofibroblasts. I. Paracrine cells important in health and disease
Am J Physiol Cell Physiol, July 1, 1999; 277(1): C1 - C19.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Z. Kirk, M. E. Mark, C. C. Chua, B. H. Chua, and M. D. Mayes
Myofibroblasts from Scleroderma Skin Synthesize Elevated Levels of Collagen and Tissue Inhibitor of Metalloproteinase (TIMP-1) with Two Forms of TIMP-1
J. Biol. Chem., February 17, 1995; 270(7): 3423 - 3428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society for Investigative Pathology.